by David Brindley | Oct 25, 2013
. Nestled in the bosom of the Canadian Rockies, the global regenerative medicine community is assembled. Coaches laden with young investigators sporting impractically packed posters and drawn, jet lagged expressions are arriving in a steady procession. The usually...
by David Brindley | Oct 24, 2013
. 9am, Day 1: IBC Cell Therapy Bioprocessing Conference (Bethesda, MD, USA): Attempting to sharpen tie, and my welcome isolation is interrupted by a lady entering the elevator and fighting for mirror space. Cue small talk: “That’s a nice tie.” “Erm, thank you.” “And...
by David Brindley | Oct 23, 2013
. The Cell Therapy Industry’s equivalent of ‘Wimbledon Fortnight,’ is upon us: ARM’s successfully delivered Meeting on the Mesa (La Jolla, CA) has served as a tantalizing hors d’oeuvre to IBC’s Cell Therapy Bioprocessing Conference (Bethesda, MD) and CCRM’s and...
by Holly Wobma | Oct 9, 2013
> For anyone following the celebrity gossip of the stem cell field, you’ve probably come across one of our rising stars, the induced pluripotent stem cell (iPSC). Award winning and deemed to have loads of potential, each one of us can produce this type of cell. The...
by Stacey Johnson | Oct 4, 2013
. With over 1,000 TED Talks, it’s inevitable that more than one good regenerative medicine talk will appear in Right Turn. The talk below, by Dr. Robert Langer of MIT, takes some commitment at nearly 18 minutes in running time, but if you’re a fan of biomaterials (or...
by Mark Curtis | Oct 3, 2013
. I have recently joined the business development group at CCRM, as an analyst, and believe it would be useful to start compiling some recaps on clinical developments in the regenerative medicine (RM) and cell therapy industries to complement the other science-related...
Comments